Workup for Thrombocytopenia
Initial Diagnostic Approach
The workup for thrombocytopenia begins with a complete blood count (CBC) with differential and immediate peripheral blood smear examination by a qualified hematologist or pathologist—this combination is sufficient for most patients under 60 years without atypical features. 1, 2
Step 1: Confirm True Thrombocytopenia
- Exclude pseudothrombocytopenia first by repeating the platelet count in a citrate or heparin tube, as EDTA-dependent platelet agglutination can falsely suggest thrombocytopenia 1, 3
- Review the peripheral smear to identify platelet clumping that would indicate pseudothrombocytopenia 1, 2
Step 2: Essential History Components
- Medication review is mandatory: Document all current and recent medications, particularly heparin, quinidine/quinine, sulfonamides, GPIIb-IIIa inhibitors, chemotherapy agents, and over-the-counter medications 1, 2
- Assess bleeding history: Evaluate for mucocutaneous bleeding (petechiae, purpura, ecchymosis), prior surgeries, and pregnancies to gauge hemostatic function 1
- Screen for systemic symptoms: Fever, weight loss, night sweats, arthralgias, or rash suggest autoimmune disease or lymphoproliferative disorders 1
- Obtain family history: Ask specifically about inherited thrombocytopenias including Wiskott-Aldrich syndrome, MYH9-related disease, and Bernard-Soulier syndrome 1
- Identify infection risk factors: HIV risk factors, recent viral illnesses, immunization history, and recent transfusions 1
Step 3: Physical Examination Findings
- Normal examination except for bleeding manifestations (petechiae, purpura, ecchymosis) is typical for immune thrombocytopenia (ITP) 1
- Moderate or massive splenomegaly indicates an alternative diagnosis such as lymphoproliferative disease or portal hypertension—not ITP 1
- Lymphadenopathy or hepatomegaly suggests underlying HIV, systemic lupus erythematosus, or lymphoproliferative disease 1
Laboratory Evaluation
Core Laboratory Tests
CBC with differential: Confirm isolated thrombocytopenia (platelet count <100 × 10⁹/L) without anemia or leukopenia 3
Peripheral blood smear assessment should show:
- Normal or slightly larger than normal platelets 1
- Consistently giant platelets indicate inherited thrombocytopenia 1
- Absence of schistocytes (which would suggest thrombotic thrombocytopenic purpura-hemolytic uremic syndrome) 1
- No leukocyte inclusions like Döhle-like bodies (which suggest MYH9-related disease) 1
- Normal red blood cell and white blood cell morphology 1
Reticulocyte count: Helps distinguish whether anemia results from bleeding (elevated reticulocytes) versus bone marrow failure 3
Coagulation studies (PT, aPTT, fibrinogen): Should be normal in ITP; abnormalities suggest disseminated intravascular coagulation 3
Mandatory Serologic Testing in Adults
All adult patients require HIV and hepatitis C virus (HCV) testing regardless of risk factors or geographic location. 1, 3
- HIV testing is crucial because thrombocytopenia may precede other HIV symptoms by years, and controlling the infection can result in complete hematologic remission 1
- HCV testing is necessary as HCV-associated thrombocytopenia is clinically indistinguishable from primary ITP 1
- Helicobacter pylori testing should be considered in adults where eradication may have clinical impact 1
Age-Based and Risk-Stratified Approach
Patients Under 60 Years with Typical Features
- History, physical examination, CBC, peripheral smear, HIV, HCV, and H. pylori testing are sufficient 1
- Bone marrow examination is NOT required for initial diagnosis in this population 1
Patients 60 Years or Older
Bone marrow examination is mandatory to exclude myelodysplastic syndromes, leukemias, or other malignancies 1
Bone Marrow Examination: Specific Indications
Bone marrow examination is required in the following situations: 1
- Age greater than 60 years (mandatory indication)
- Systemic symptoms: Fever, weight loss, bone pain, or constitutional symptoms
- Abnormal blood counts: Anemia not proportional to bleeding, leukopenia, or leukocytosis
- Atypical smear findings: Schistocytes, leukocyte inclusion bodies, or dysplastic features
- Treatment failure: Persistent thrombocytopenia lasting more than 6-12 months or unresponsive to IVIg 4, 1
- Pre-splenectomy evaluation in selected cases 1
Bone marrow testing components should include: 1
- Morphologic assessment (both aspirate and biopsy)
- Flow cytometry (particularly helpful for identifying chronic lymphocytic leukemia-associated ITP)
- Cytogenetic testing to exclude clonal disorders
Additional Context-Based Testing
- Quantitative immunoglobulin levels should be considered in children with ITP, especially those with persistent or chronic disease, to exclude common variable immunodeficiency 4, 1
- Direct antiglobulin test may be useful in selected cases 1
- Blood group Rh(D) typing is important if anti-D immunoglobulin therapy is being considered 1
- Pregnancy test should be performed in women of childbearing potential 1
Severity-Based Urgency
Platelet count <10,000/μL is a hematologic emergency requiring immediate hospitalization and urgent evaluation. 2
- Platelet count 10,000-20,000/μL: Increased risk of bleeding with minimal trauma; may require hospitalization if significant mucosal bleeding or comorbidities present 2
- Platelet count >50,000/μL: Generally asymptomatic 5
- Platelet count 20-50,000/μL: May have mild skin manifestations such as petechiae, purpura, or ecchymosis 5
Common Pitfalls to Avoid
- Do not perform routine bone marrow examination in patients under 60 years with typical ITP features, as this is unnecessary and increases cost and patient burden 4, 1
- Do not skip HIV/HCV testing even in low-risk patients, as these infections can present with isolated thrombocytopenia years before other symptoms 1, 3
- Do not assume ITP in patients with splenomegaly, lymphadenopathy, or other cytopenias—these require bone marrow examination 1
- Always confirm true thrombocytopenia by excluding pseudothrombocytopenia before proceeding with extensive workup 1, 2